Document is current

Any future updates will be listed below

The Non-Significant Benefit of BCG Vaccination for the Treatment of Iranian Patients with Type 1 Diabetes up to 48 Weeks: A Controversial Result

Crossref DOI link: https://doi.org/10.47176/mjiri.35.161

Published Online: 2021-10-30

Update policy: https://doi.org/10.47176/mjiri/crossmark_policy

About CrossMark